LHC Group (LHCG) Scheduled to Post Quarterly Earnings on Wednesday

Share on StockTwits

LHC Group (NASDAQ:LHCG) will be issuing its quarterly earnings data after the market closes on Wednesday, August 7th. Analysts expect the company to announce earnings of $1.00 per share for the quarter. LHC Group has set its FY 2019 guidance at $4.25-4.35 EPS and its FY19 guidance at $4.25-$4.35 EPS.Parties interested in registering for the company’s conference call can do so using this link.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.08. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. The company had revenue of $502.59 million during the quarter, compared to analysts’ expectations of $511.16 million. On average, analysts expect LHC Group to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

LHC Group stock opened at $120.23 on Tuesday. The company has a 50-day simple moving average of $121.28. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57. LHC Group has a one year low of $80.84 and a one year high of $129.37. The stock has a market capitalization of $3.89 billion, a PE ratio of 33.87, a PEG ratio of 2.10 and a beta of 0.84.

In other news, Director John L. Indest sold 30,515 shares of the stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $113.76, for a total value of $3,471,386.40. Following the transaction, the director now directly owns 22,947 shares of the company’s stock, valued at $2,610,450.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Donald Dwayne Stelly sold 448 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $120.00, for a total value of $53,760.00. Following the completion of the transaction, the chief operating officer now directly owns 91,252 shares in the company, valued at $10,950,240. The disclosure for this sale can be found here. Insiders sold 46,269 shares of company stock worth $5,314,613 over the last three months. Corporate insiders own 5.20% of the company’s stock.

LHCG has been the subject of a number of research analyst reports. BidaskClub upgraded LHC Group from a “buy” rating to a “strong-buy” rating in a research note on Friday. Royal Bank of Canada increased their price target on LHC Group to $130.00 and gave the company an “outperform” rating in a research note on Monday, May 13th. Jefferies Financial Group increased their price objective on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. Barclays reissued a “hold” rating on shares of LHC Group in a report on Sunday, May 12th. Finally, UBS Group set a $133.00 price objective on LHC Group and gave the company a “buy” rating in a report on Friday, May 10th. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $122.70.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Further Reading: What are catch-up contributions?

Earnings History for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sabre Corp  Shares Bought by Cpwm LLC
Sabre Corp Shares Bought by Cpwm LLC
Research Analysts’ New Coverage for August, 19th
Research Analysts’ New Coverage for August, 19th
Equities Research Analysts’ Price Target Changes for August, 19th
Equities Research Analysts’ Price Target Changes for August, 19th
Stock Analysts’ Updated EPS Estimates for August, 19th
Stock Analysts’ Updated EPS Estimates for August, 19th
Microchip Technology Inc.  Declares Quarterly Dividend of $0.37
Microchip Technology Inc. Declares Quarterly Dividend of $0.37
Cedar Capital LLC Increases Stake in ISHARES TR/3-7 YR TREAS BD ETF
Cedar Capital LLC Increases Stake in ISHARES TR/3-7 YR TREAS BD ETF


© 2006-2019 Ticker Report